Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Leukotriene modifiers].

K Minoguchi1, M Adachi

  • 1First Department of Internal Medicine, Showa University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 26, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2010
Same author

Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2007
Same author

Association between lipid peroxidation and inflammation in obstructive sleep apnoea.

The European respiratory journal·2006
Same author

Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2006
Same author

Suplatast tosilate inhibits thymus- and activation-regulated chemokine production by antigen-specific human Th2 cells.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2003
Same author

Cough receptor sensitivity to capsaicin does not change after allergen bronchoprovocation in allergic asthma.

Thorax·2003
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Cysteinyl leukotrienes (CysLTs) are key mediators in asthma, causing bronchoconstriction and inflammation. CysLT1 receptor antagonists effectively manage asthma, particularly in symptomatic or steroid-naive patients.

Area of Science:

  • Immunology
  • Pharmacology
  • Respiratory Medicine

Background:

  • Cysteinyl leukotrienes (CysLTs) are potent inflammatory mediators implicated in asthma pathogenesis.
  • CysLTs are produced by various immune cells, including eosinophils, mast cells, macrophages, and neutrophils, upon cellular activation.
  • Key CysLT actions include bronchoconstriction, increased vascular permeability, mucus hypersecretion, and eosinophil recruitment.

Purpose of the Study:

  • To review the role of CysLTs and their receptors in asthma.
  • To highlight the distribution and function of CysLT1 receptors in airway inflammation.
  • To discuss the therapeutic efficacy of CysLT1 receptor antagonists in asthma management.

Main Methods:

  • Literature review of studies on CysLTs, CysLT1 receptors, and asthma.

Related Experiment Videos

  • Analysis of pharmacological actions and cellular distribution of CysLTs.
  • Evaluation of clinical data on CysLT1 receptor antagonist efficacy.

    • Main Results:

    • CysLT1 receptors are expressed on various cells, including airway smooth muscle, stem cells, and immune cells.
    • CysLTs contribute significantly to asthma pathophysiology through multiple mechanisms.
    • CysLT1 receptor antagonists demonstrate clinical benefit in managing asthma symptoms.

    Conclusions:

    • CysLTs are critical players in asthma, mediating key inflammatory processes.
    • The widespread distribution of CysLT1 receptors underscores their importance in airway inflammation.
    • CysLT1 receptor antagonists represent a valuable therapeutic option for asthma control.